TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard‐of‐Care Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.31915
Abstract: Extrahepatic portal vein occlusion (EHPVO) from portal vein thrombosis is a rare condition associated with substantial morbidity and mortality. The purpose of this study is to investigate the efficacy of transjugular intrahepatic portosystemic shunts (TIPS)… read more here.
Keywords: venous thrombosis; refractory standard; mesenteric venous; adults without ... See more keywords
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2018.03.007
Abstract: BACKGROUND & AIMS Glecaprevir plus pibrentasvir (G/P) is a pangenotypic, once-daily, ribavirin-free direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection. In nine phase II or III clinical trials, G/P therapy achieved rates of… read more here.
Keywords: week; analysis; treatment; infection ... See more keywords
Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-65529-5
Abstract: The aim of the study was to identify the characteristics and outcomes in acute-on-chronic liver failure (ACLF) patients with or without cirrhosis using two criteria. Patients with acute deterioration of chronic hepatic disease or acute… read more here.
Keywords: aclf patients; cirrhosis; easl aclf; aclf ... See more keywords
Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000001062
Abstract: Background: Hepatocellular carcinoma (HCC) accounts for 90% of primary hepatic malignancies. With the exception of chronic hepatitis B (CHB), other etiologies of chronic liver disease require progression to cirrhosis before HCC development. Case reports have… read more here.
Keywords: hcc; histology; without cirrhosis; liver ... See more keywords
Should Patients With NAFLD/NASH Be Surveyed for HCC?
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation"
DOI: 10.1097/tp.0000000000002361
Abstract: Background Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance… read more here.
Keywords: patients without; hcc; nafld patients; incidence ... See more keywords
Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.12642
Abstract: The association between HBV infection and incident thrombocytopenia among subjects without cirrhosis or splenomegaly is unknown. Therefore, we sought to elucidate the association between HBV infection and the development of thrombocytopenia in a large cohort… read more here.
Keywords: thrombocytopenia; hepatitis; infection; incident thrombocytopenia ... See more keywords
Clinicopathologic and MRI features of combined hepatocellular‐cholangiocarcinoma in patients with or without cirrhosis
Sign Up to like & getrecommendations! Published in 2021 at "Liver International"
DOI: 10.1111/liv.14798
Abstract: Differences in combined hepatocellular‐cholangiocarcinomas (cHCC‐CCAs) arising in high‐risk patients with or without liver cirrhosis have not been elucidated. This study aimed to compare the clinicopathologic and imaging characteristics of cHCC‐CCAs in patients with or without… read more here.
Keywords: combined hepatocellular; clinicopathologic mri; cirrhosis; chcc ccas ... See more keywords
Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and Mortality
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126177
Abstract: Introduction: The presence of underlying cirrhosis poses a serious challenge in treatment of newly diagnosed acute myeloid leukemia (AML) patients. In current practice, patients with significant hyperbilirubinemia are precluded from optimal induction and consolidation therapy.… read more here.
Keywords: chemotherapy; cirrhosis; patients aml; mortality ... See more keywords
Distribution of insulin growth factor-1 (IGF-1) binding proteins in hepatocellular carcinoma with and without cirrhosis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.193
Abstract: 193 Background: Circulating insulin-like growth factor-1 (IGF-1) significantly declines in patients (pts) with cirrhosis and hepatocellular carcinoma (HCC), reflecting damaged hepatocytes. The bioavailability of IGF-1 is controlled by insulin-like growth factor binding proteins (IGFBPs), which… read more here.
Keywords: cirrhotic hcc; hcc; without cirrhosis; growth factor ... See more keywords
Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0244939
Abstract: Background/Aims A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients.… read more here.
Keywords: cirrhotic patients; cirrhosis; non cirrhotic; without cirrhosis ... See more keywords
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
Sign Up to like & getrecommendations! Published in 2023 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v29.i2.343
Abstract: Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of patients with HCC had no clinical or histological evidence of cirrhosis.… read more here.
Keywords: hepatocellular carcinoma; without cirrhosis; non alcoholic; cirrhosis ... See more keywords